Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview and Outlook Report 2019

Table of Contents

1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview 1

• 1.1 Product Overview and Scope of PARP (Poly ADP-Ribose Polymerase) Inhibitor 1
• 1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Types 2
  • 1.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate Comparison by Types 2
  • 1.2.2 Lynparza 4
  • 1.2.3 Zejula 5
  • 1.2.4 Rubraca 5
  • 1.2.5 Talzenna 6
• 1.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Applications 6
  • 1.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Comparison by Applications 6
  • 1.3.2 Ovarian Cancer 8
  • 1.3.3 Breast Cancer 9
• 1.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Regions 9
  • 1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Regions 10
  • 1.4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2014-2025) 11
  • 1.4.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2014-2025) 11
  • 1.4.4 Emerging Country PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2014-2025) 12
• 1.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 13
  • 1.5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2014-2025) 13
  • 1.5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production (2014-2025) 14

2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competition by Manufacturers 15

• 2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Manufacturers (2014-2019) 15
• 2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Manufacturers (2014-2019) 17
• 2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price by Manufacturers (2014-2019) 19
• 2.4 Manufacturers PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Sites, Area Served, Product Types 21
• 2.5 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competitive Situation and Trends 22
  • 2.5.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Concentration Rate 22
  • 2.5.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share of Top 3 and Top 5 Manufacturers 23
  • 2.5.3 Mergers & Acquisitions, Expansion 24

3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production by Regions (2014-2019) 26

• 3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Regions 26
• 3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Regions (2014-2019) 28
• 3.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019) 30
• 3.4 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production 30
  • 3.4.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019) 30
  • 3.4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019) 31
• 3.5 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production 31
  • 3.5.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019) 31
  • 3.5.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019) 32

4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Regions 33

• 4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Regions 33
• 4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019) 35
• 4.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019) 36
• 4.4 Emerging Country PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019) 37

5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price Trend by Types 38

• 5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Types (2014-2019) 38
• 5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Types (2014-2019) 40
• 5.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price by Type (2014-2019) 42
• 5.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth by Type (2014-2019) 42

6 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Analysis by Applications 43

• 6.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Share by Applications (2014-2019) 43
• 6.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Growth Rate by Applications (2014-2019) 45

7 Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Key Manufacturers 46

• 7.1 AstraZeneca 46
  • 7.1.1 Company Profile 46
  • 7.1.2 Product Information 47
  • 7.1.3 Production, Price and Revenue 47
• 7.2 Tesaro 48
  • 7.2.1 Company Profile 48
  • 7.2.2 Product Information 49
  • 7.2.3 Production, Price and Revenue 49
• 7.3 Merck & Co 50
  • 7.3.1 Company Profile 50
  • 7.3.2 Product Information 51
  • 7.3.3 Production, Price and Revenue 51
• 7.4 Clovis Oncology 51
  • 7.4.1 Company Profile 51
  • 7.4.2 Product Information 53
  • 7.4.3 Production, Price and Revenue 53
• 7.5 Pfizer 54
  • 7.5.1 Company Profile 54
  • 7.5.2 Product Information 55
  • 7.5.3 Production, Price and Revenue 56

8 PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Cost Analysis 57

• 8.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor R&D Cost Analysis 57
  • 8.1.1 Clinical Phase Costs 58
  • 8.1.2 Capitalized Costs 59
• 8.2 Proportion of Manufacturing Cost Structure 60
  • 8.2.1 Raw Materials 60
  • 8.2.2 Labor Cost 61
    • 8.2.2.1 USA Labor Cost Analysis 61
    • 8.2.2.2 Europe Labor Costs Analysis 63
    • 8.2.2.3 Asia Labor Costs Analysis 65
  • 8.2.3 Other Costs Analysis 67
    • 8.2.3.1 USA Cost of Electricity Analysis 68
    • 8.2.3.2 USA Water Cost Analysis 68
    • 8.2.3.3 Europe Cost of Electricity Analysis 69
    • 8.2.3.4 Europe Water Cost Analysis 70
    • 8.2.3.5 China Cost of Electricity Analysis 70
    • 8.2.3.6 China Water Cost Analysis 71
• 8.3 Manufacturing Process Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor 72
• 8.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industrial Chain Analysis 73

9 Marketing Channel, Distributors and Customers 74

• 9.1 Marketing Channel 74
• 9.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Distributors List 76
• 9.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Customers 79

10 Market Dynamics 81

• 10.1 Market Trends 81
• 10.2 Opportunities 83
  • 10.2.1 Ovarian Cancer 84
  • 10.2.2 Breast Cancer 87
• 10.3 Market Drivers 89
• 10.4 Challenges 90
• 10.5 Influence Factors 90
  • 10.5.1 GDP for Major Regions 92
  • 10.5.2 Population and Labor Considered for Forecast 94
  • 10.5.3 Disposable Income Considered for Forecast 96

11 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Forecast 98

• 11.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast 98
  • 11.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate Forecast (2019-2025) 98
  • 11.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate Forecast (2019-2025) 99
  • 11.1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price and Trend Forecast (2019-2025) 100
• 11.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Forecast by Regions (2019-2025) 100
  • 11.2.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025) 102
  • 11.2.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025) 103
• 11.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast by Regions (2019-2025) 104
  • 11.3.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025) 105
  • 11.3.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025) 106
  • 11.3.3 Emerging Country PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025) 107
• 11.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue and Price Forecast by Type (2019-2025) 107
• 11.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast by Application (2019-2025) 110

12 Research Findings and Conclusion 111

13 Methodology and Data Source 112

• 13.1 Methodology/Research Approach 112
  • 13.1.1 Research Programs/Design 112
  • 13.1.2 Market Size Estimation 113
  • 13.1.3 Market Breakdown and Data Triangulation 114
• 13.2 Data Source 116
  • 13.2.1 Secondary Sources 116
  • 13.2.2 Primary Sources 117
• 13.3 Author List 119